Literature DB >> 6876438

[Current status and future of brachytherapy].

Y Shigematsu, N Masaki, H Ikeda, K Nishiyama, K Morimoto, S Ozeki.   

Abstract

This paper reviewed the development of brachytherapy for the past and at present. In Japan, remotely controlled high-dose-rate afterloading intracavitary treatment for uterine cervix carcinoma has become quite common and interstitial radiotherapy with 192Ir hairpin technique for intraoral carsinomas has also been in routine practice at an increased number of institutes in Japan. These has played a great role in eliminating the personnel exposure. Our present efforts are now directed to extend indications to some other cancers, such as bile-duct, pancreas, rectum and prostate. Nearly 20 patients with intraluminal insertion of 192Ir-wire and template technique with 192Ir-wire has just started to apply for rectal had prostate cancer. Permanent implant of 125I has been also of much interest.

Entities:  

Mesh:

Year:  1983        PMID: 6876438

Source DB:  PubMed          Journal:  Gan No Rinsho        ISSN: 0021-4949


  4 in total

1.  Edema worsens target coverage in high-dose-rate interstitial brachytherapy of mobile tongue cancer: a report of two cases.

Authors:  Ken Yoshida; Hideya Yamazaki; Tadayuki Kotsuma; Hironori Akiyama; Tadashi Takenaka; Koji Masui; Yasuo Yoshioka; Yasuo Uesugi; Taiju Shimbo; Nobuhiko Yoshikawa; Hiroto Yoshioka; Takumi Arika; Eiichi Tanaka; Yoshifumi Narumi
Journal:  J Contemp Brachytherapy       Date:  2017-01-16

2.  Dose reduction trial from 60 Gy in 10 fractions to 54 Gy in 9 fractions schedule in high-dose-rate interstitial brachytherapy for early oral tongue cancer.

Authors:  Hironori Akiyama; Ken Yoshida; Kimishige Shimizutani; Hideya Yamazaki; Masahiko Koizumi; Yasuo Yoshioka; Naoya Kakimoto; Shumei Murakami; Souhei Furukawa; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2012-06-28       Impact factor: 2.724

Review 3.  High dose rate brachytherapy for oral cancer.

Authors:  Hideya Yamazaki; Ken Yoshida; Yasuo Yoshioka; Kimishige Shimizutani; Souhei Furukawa; Masahiko Koizumi; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2012-11-23       Impact factor: 2.724

4.  Three-dimensional image-based high-dose-rate interstitial brachytherapy for mobile tongue cancer.

Authors:  Ken Yoshida; Tadashi Takenaka; Hironori Akiyama; Hideya Yamazaki; Mineo Yoshida; Koji Masui; Tadayuki Kotsuma; Sungjae Baek; Yasuo Uesugi; Taiju Shimbo; Nobuhiko Yoshikawa; Takumi Arika; Yukihiro Koretsune; Yasuo Yoshioka; Yoshifumi Narumi; Eiichi Tanaka
Journal:  J Radiat Res       Date:  2013-06-03       Impact factor: 2.724

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.